Literature DB >> 11526452

Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting.

A Aints1, H Güven, G Gahrton, C I Smith, M S Dilber.   

Abstract

The herpes simplex virus 1 (HSV-1) tegument protein VP22 has been utilised as a vehicle for trafficking proteins. It has a remarkable property of exiting the cell that is producing it and entering the neighbouring cells, which has been used to deliver therapeutic proteins, p53 and herpes simplex virus thymidine kinase (tk). It has a complex pattern of expression and subcellular localisation. Functions of VP22 include intercellular transport, binding to and bundling of microfilaments, inducing cytoskeleton collapse, nuclear translocation during mitosis, and binding to chromatin and nuclear membrane. The regions of VP22 which contain each of these functions have not been characterised. Finding the region carrying the property of intercellular spread would facilitate enhancement of transport function. By constructing a series of deletion constructs of VP22 tagged by the green fluorescent protein (GFP) we have mapped the functions of VP22 to specific regions in the polypeptide as follows: intercellular transport - aa 81-195; binding and reorganisation of cytoskeleton - aa 159-267; nuclear targeting, inhibition of cytoskeleton collapse - aa 81-121; and nuclear targeting and facilitation of intercellular transport - aa 267-301. Separation of VP22 functions enables focus on the mechanism of VP22-mediated transport and improve the transportation efficiency of VP22.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526452     DOI: 10.1038/sj.gt.3301493

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  15 in total

1.  Herpes simplex virus tegument protein VP22 contains overlapping domains for cytoplasmic localization, microtubule interaction, and chromatin binding.

Authors:  Ana Martin; Peter O'Hare; John McLauchlan; Gillian Elliott
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  The role of the cytoskeleton in the life cycle of viruses and intracellular bacteria: tracks, motors, and polymerization machines.

Authors:  E L Bearer; P Satpute-Krishnan
Journal:  Curr Drug Targets Infect Disord       Date:  2002-09

3.  VP22 fusion protein-based dominant negative mutant can inhibit hepatitis B virus replication.

Authors:  Jun Yi; Wei-Dong Gong; Ling Wang; Rui Ling; Jiang-Hao Chen; Jun Yun
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

4.  Efficient dose-dependent and time-dependent protein transduction of pancreatic carcinoma cells in vitro and in vivo using purified VP22-EGFP fusion protein.

Authors:  Lars Boenicke; Kang Chu; Regina Pauls; Claudia Tams; Marie-Luise Kruse; Roland Kurdow; Bodo Schniewind; Arnd Böhle; Bernd Kremer; Holger Kalthoff
Journal:  J Mol Med (Berl)       Date:  2003-03-18       Impact factor: 4.599

Review 5.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

6.  Membrane association of VP22, a herpes simplex virus type 1 tegument protein.

Authors:  Michael J Brignati; Joshua S Loomis; John W Wills; Richard J Courtney
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

7.  Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen.

Authors:  Chien-Fu Hung; Liangmei He; Jeremy Juang; Tzyy-Jye Lin; Morris Ling; T-C Wu
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

8.  Mapping Murine Corneal Neovascularization and Weight Loss Virulence Determinants in the Herpes Simplex Virus 1 Genome and the Detection of an Epistatic Interaction between the UL and IRS/US Regions.

Authors:  Kyubin Lee; Aaron W Kolb; Inna Larsen; Mark Craven; Curtis R Brandt
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

9.  The varicella-zoster virus (VZV) ORF9 protein interacts with the IE62 major VZV transactivator.

Authors:  Cristian Cilloniz; Wallen Jackson; Charles Grose; Donna Czechowski; John Hay; William T Ruyechan
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  Purification of full-length VP22 from cells infected with HSV-1: A two-pronged approach for the solubilization and purification of viral proteins for use in biochemical studies.

Authors:  Ebony J Dewberry; Eric Dunkerley; Carol Duffy
Journal:  J Virol Methods       Date:  2012-04-28       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.